全文获取类型
收费全文 | 38214篇 |
免费 | 3175篇 |
国内免费 | 81篇 |
专业分类
耳鼻咽喉 | 291篇 |
儿科学 | 1708篇 |
妇产科学 | 1184篇 |
基础医学 | 5188篇 |
口腔科学 | 398篇 |
临床医学 | 4654篇 |
内科学 | 7014篇 |
皮肤病学 | 681篇 |
神经病学 | 4519篇 |
特种医学 | 722篇 |
外科学 | 3710篇 |
综合类 | 353篇 |
现状与发展 | 1篇 |
一般理论 | 74篇 |
预防医学 | 5226篇 |
眼科学 | 596篇 |
药学 | 2505篇 |
中国医学 | 35篇 |
肿瘤学 | 2611篇 |
出版年
2024年 | 81篇 |
2023年 | 618篇 |
2022年 | 985篇 |
2021年 | 1951篇 |
2020年 | 1156篇 |
2019年 | 1674篇 |
2018年 | 1880篇 |
2017年 | 1271篇 |
2016年 | 1438篇 |
2015年 | 1494篇 |
2014年 | 1962篇 |
2013年 | 2459篇 |
2012年 | 3566篇 |
2011年 | 3448篇 |
2010年 | 1726篇 |
2009年 | 1483篇 |
2008年 | 2275篇 |
2007年 | 2364篇 |
2006年 | 1998篇 |
2005年 | 1832篇 |
2004年 | 1567篇 |
2003年 | 1294篇 |
2002年 | 1166篇 |
2001年 | 149篇 |
2000年 | 110篇 |
1999年 | 177篇 |
1998年 | 230篇 |
1997年 | 136篇 |
1996年 | 114篇 |
1995年 | 115篇 |
1994年 | 106篇 |
1993年 | 98篇 |
1992年 | 55篇 |
1991年 | 46篇 |
1990年 | 40篇 |
1989年 | 29篇 |
1988年 | 24篇 |
1987年 | 23篇 |
1986年 | 28篇 |
1985年 | 31篇 |
1984年 | 30篇 |
1983年 | 24篇 |
1982年 | 25篇 |
1981年 | 26篇 |
1980年 | 30篇 |
1979年 | 18篇 |
1978年 | 15篇 |
1977年 | 10篇 |
1974年 | 8篇 |
1972年 | 12篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
92.
Andrew C Hartwig Sarah I Mathias Alan S Law G F Gebhart 《Journal of oral and maxillofacial surgery》2003,61(11):1302-1309
PURPOSE: Experimental inflammation of the rat temporomandibular joint (TMJ) is commonly used to study trigeminal nociceptive processing. This study describes spontaneous pain-related behaviors following TMJ inflammation in the rat. The ability of preemptive systemic morphine to attenuate behaviors as well as immediate-early gene expression in the trigeminal nucleus is described. MATERIALS AND METHODS: Adult male Sprague-Dawley rats received an intra-articular injection of mustard oil (0% to 20%, 50 microL) and were observed for behavioral changes. Morphine sulfate (0 to 10 mg/kg SC) was given 30 minutes before mustard oil; this was reversed in one group with naltrexone hydrochloride (5 mg/kg SC). Two hours after injection rats were killed and perfused. Immunohistochemistry for the protein product of the immediate-early gene c-fos was performed, and brain stem sections including the trigeminal subnucleus caudalis were examined for positive nuclei. RESULTS: Mustard oil inflammation of the rat TMJ induces dose-dependent, morphine-sensitive behaviors. Behaviors observed included excessive grooming of the region, a chewing-like behavior, and head shaking. Fos expression in the trigeminal subnucleus caudalis parallels changes in behaviors. Morphine dose dependently attenuates the number of behaviors, as well as Fos expression; this effect is reversed by the micro-opioid receptor antagonist naltrexone. CONCLUSIONS: Mustard oil inflammation of the rat TMJ causes reliable behavioral changes, which may be quantified and, together with Fos expression, used to assess various experimental TMJ treatment modalities. 相似文献
93.
94.
Xuyu Zu Ruilan Yan Sarah Robbins Paulette A Krishack Duan-Fang Liao Deliang Cao 《Toxicological sciences》2007,97(2):562-568
Acrolein is a highly reactive alpha,beta-unsaturated aldehyde produced endogenously during lipid peroxidation and naturally distributed pervasively in living environments, posing serious threats to human health if not properly metabolized. In this study, we report aldose reductase-like-1 (ARL-1) as a novel enzyme that catalyzes the reduction of acrolein and protects cells from their toxicity. Using purified ARL-1 protein, we determined its enzymatic activity in response to acrolein and defined its steady-state kinetics with K(m) and V(max) at 0.110 +/- 0.012 mM and 3122.0 +/- 64.7 nmol/mg protein/min, respectively. By introducing a functional Enhanced Green Fluorescent Protein (EGFP)/ARL-1 fusion protein into 293T cells, we demonstrated that plating efficiency in liquid culture and focus formation in soft agar increased by more than 60% (p < 0.05), compared to the vector control cells. More significantly, at a low dose of 5 microM acrolein, EGFP/ARL-1 expression enhanced both plating efficiency and focus formation by more than threefold, and the foci (in soft agar) of 293T cells expressing EGFP/ARL-1 were significantly larger than those of the vector control cells. At high concentrations of acrolein (25 and 50 microM), EGFP/ARL-1 protein prevented oncotic death of 293T cells induced by acrolein. In summary, our data demonstrated for the first time that the ARL-1 protein protects 293T cells from acrolein toxicity. Due to the high toxicity and wide distribution of acrolein, this finding is important to the understanding of its detoxification mechanisms. 相似文献
95.
Sarah N. Flier M.D. Suzanne Rose M.D. M.S.Ed. 《The American journal of gastroenterology》2006,101(S3):S644-S653
Dyspepsia is a remarkably common symptom in the general population. Although multiple definitions have been used to describe the symptom, the most common explanation is that of chronic or recurrent pain or discomfort (a subjective negative feeling that may be associated with early satiety, fullness, bloating, or nausea) centered in the upper abdomen. When a thorough evaluation of a dyspeptic patient fails to identify a cause for her symptoms, the label of nonulcer or functional dyspepsia is applied. Functional dyspepsia is a heterogeneous disorder characterized by relapsing and remitting symptoms. Treatment strategies should focus on alleviating the most bothersome symptom and can be based on the proposed underlying pathophysiology. The effect of gender on mechanisms of disease, symptom presentation, and treatment response is an area of increasing interest and study. As with other functional gastrointestinal disorders, there appear to be some gender-specific features of functional dyspepsia. Specifically, gender-related differences have been observed in some studies of both the prevalence of individual dyspepsia symptoms, and in gastric emptying and proximal gastric motor function. There also appear to be gender differences in the psychosocial realm, with dyspeptic women experiencing a lesser sense of well-being than dyspeptic men, as well as an association of an abuse history with functional dyspepsia. This review will highlight specific gender differences related to the symptom presentation, pathophysiology, and approach to treatment of functional dyspepsia, while noting where differences have not been found and where further investigation is warranted. 相似文献
96.
97.
98.
99.
BACKGROUND: Levofloxacin is used in adult patients with cystic fibrosis but its pharmacokinetics is not well characterized in this population. Patients with cystic fibrosis use calcium routinely to prevent osteoporosis. A slower intestinal transit time is common in cystic fibrosis implying that the standard 2-h spacing of minerals and levofloxacin to prevent a chelation interaction may be insufficient. The objectives of this study were to characterize the steady state pharmacokinetics of oral levofloxacin 750 mg with and without 2-h spaced calcium carbonate in patients with cystic fibrosis compared to matched healthy volunteers. METHODS: In an open-label, randomized, cross-over study of five patients with cystic fibrosis and five age, sex, race, and serum creatinine matched healthy volunteers received 750 mg of oral levofloxacin alone daily for 5 days and the same dose of levofloxacin with 2-h spaced calcium carbonate supplementation 500 mg po thrice daily with meals in random sequence. Blood was collected for plasma assay of levofloxacin pre-dose, 0.5, 1, 1.5, 2, 4, 8, 12, and 24h after the fifth levofloxacin dose. RESULTS: There was no significant interaction in healthy volunteers, however, when cystic fibrosis patients were given levofloxacin with 2-h spaced calcium, the maximum plasma concentration (Cmax) decreased by 19% and time to Cmax increased by 37% (p<0.05). This difference in peak concentrations resulted in a lack of bioequivalence (Cmax geometric mean ratio 81.6%, 90% confidence intervals: 71.8%, 91.4%) even when levofloxacin and calcium supplements were spaced by the standard 2h administration instruction in patients with cystic fibrosis. CONCLUSIONS: These results indicate that multivalent cations such as calcium should be maximally separated from oral levofloxacin administration in adult patients with cystic fibrosis to prevent this drug interaction, thereby better optimizing antibiotic efficacy and decreasing the potential for resistance development. 相似文献
100.